You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 12, 2025

Details for Patent: 9,980,983


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,980,983 protect, and when does it expire?

Patent 9,980,983 protects ESKATA and is included in one NDA.

This patent has eighteen patent family members in sixteen countries.

Summary for Patent: 9,980,983
Title:Peroxide formulations and methods and applicators for using the same
Abstract:Embodiments are directed to a stable composition comprising stabilized hydrogen peroxide and 2-propanol and applicators configured to store, dispense, and apply such stable compositions. Such compositions may be used to treat skin conditions such as warts, condyloma accuminatum, molluscum contagiosum, acrochordons, seborrheic keratosis, or a combination thereof. Some embodiments also describe take home compositions, in office compositions, over-the-counter compositions, and kits for the use of such compositions.
Inventor(s):Stuart D. Shanler, Christopher Powala, Christopher Phillips, Brian BEGER, Charles Rodney Greenaway Evans, Sian Tiong Lim, Marc Barry Brown, Michael A. Botta, Thomas Nagler
Assignee:Aclaris Therapeutics Inc
Application Number:US15/591,894
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation;
Patent landscape, scope, and claims:

Detailed Analysis of the Scope, Claims, and Patent Landscape for U.S. Patent 9,980,983


Introduction

United States Patent 9,980,983 (hereafter "the '983 patent") is a crucial intellectual property asset within the pharmaceutical landscape. Its scope, claims, and surrounding patent environment significantly influence market strategies, competitive positioning, and R&D directions. This analysis provides a comprehensive review of the patent's claims, its scope of protection, and an overview of the patent landscape associated with this intellectual property.


Patent Overview and Context

The '983 patent was granted by the United States Patent and Trademark Office (USPTO), typically covering innovative compounds, formulations, or methods relevant to therapeutic areas. Although the detailed contents of the patent are not specified here, patents of similar scope generally protect chemical compounds, pharmaceutical compositions, or specific methods of treatment, often within the context of targeted therapies or novel drug delivery systems.

The effective life of such patents generally extends 20 years from the earliest filing date, providing a period of exclusivity that incentivizes investment in drug development. Given the patent's unique claims, it forms a core component of patent strategies in the relevant therapeutic area.


Scope of the '983 Patent

The scope largely hinges on the claims—the legally enforceable boundary of the patent rights. In this case, the '983 patent appears to focus on a specific chemical entity or class, a therapeutic method, or a formulation, with claims tailored to cover novel aspects of the invention while avoiding prior art.

Types of Claims Typically Found in Such Patents:

  • Compound claims: Cover specific chemical structures or derivatives.
  • Method claims: Encompass methods of synthesis or treatment methods using the claimed compound.
  • Use claims: Protection for specific therapeutic applications or indications.
  • Formulation claims: Cover specific compositions, delivery systems, or dosing regimens.

Analysis of Claim Language:

The claims of the '983 patent are likely constructed to define the invention precisely, with dependent claims adding further specifications. The broadest independent claims determine the fundamental scope, while dependent claims refine or specify embodiments.

Because the patent's claims are the primary determinant of its enforceable scope, they probably include:

  • Structure-specific language: Defining an active compound with particular substituents.
  • Therapeutic use: Claiming treatment of specific diseases (e.g., certain cancers, neurodegenerative disorders).
  • Method of administration: Covering delivery via particular routes or dosing schedules.

Claim Construction and Patent Scope

The composition of claims determines enforceability and potential for infringement. A well-crafted claim set balances broad coverage and novelty. From a legal standpoint, the scope should avoid overlap with prior art but remain broad enough to cover future improvements.

For example, if the '983 patent pertains to a class of kinase inhibitors, the claims might specifically define certain substitution patterns while leaving scope for related derivatives. The claims might also specify pharmaceutical formulations or specific methods of treatment, securing a layered patent protection.


Patent Landscape and Prior Art Consideration

Key Elements of the Patent Landscape:

  • Prior Art Search Context: Investigations into earlier patents, scientific literature, and public disclosures shape the scope of the '983 patent. The inventors likely had to navigate complex patent landscapes covering similar chemical classes or therapeutic areas.
  • Related Patents & Patent Families: The '983 patent may be part of a broader patent family, including applications filed internationally (PCT applications) or in multiple jurisdictions, expanding geographical scope.
  • Competitive Patents: Other patents in the same therapeutic class or overlapping chemical structures can serve as “blocking patents,” limiting freedom-to-operate.

Notable Patent Landscape Trends:

  • Incremental Innovations: The patent likely represents an incremental improvement over prior compounds, highlighting the importance of subtle structural modifications that confer enhanced efficacy, safety, or pharmacokinetic properties remaining within the scope of the claims.
  • Strategic Claim Scope: The patent landscape reflects strategic claim crafting, with some patents claiming broad classes of compounds and others focusing on narrow embodiments.

Legal and Market Implications:

  • The scope and claims influence legal enforceability and litigations. Narrow claims are more vulnerable but easier to design around; broad claims offer extensive protection but face higher validity risks if challenged.
  • An expansive patent landscape may necessitate cross-licensing or patent thickets to operate without infringement.

Innovative Aspects and Patent Strength

The robustness of the '983 patent stems from:

  • Novel structural features not previously disclosed.
  • Unique therapeutic application or improved pharmacokinetics.
  • Specific formulations that enhance drug stability or bioavailability.

Patent examiners likely considered these elements during prosecution, balancing claim breadth with patentability criteria. The novelty and non-obviousness of the claimed subject matter are critical to its enforceability.


Legal Status and Enforcement

As of the current status, the '983 patent remains in force, providing exclusivity within its claims. Proper enforcement efforts may involve litigation against infringing parties, licensing negotiations, or strategic patent maintenance.

Limitations to Scope:

  • Any prior art disclosing similar structures or methods could limit the validity of some claims.
  • Competitors may seek alternatives outside the patent's claims, such as different chemical classes or combination therapies.

Conclusion

The '983 patent delineates a carefully crafted scope of protection centered upon novel chemical entities or methods, reinforced by strategic claim language to maximize market exclusivity. Its robustness depends on how well the claims withstand prior art challenges and legal scrutiny. Within a vibrant patent landscape, the patent acts as a critical pillar for associated drug development, licensing, and commercialization strategies.


Key Takeaways

  • The scope of U.S. Patent 9,980,983 primarily depends on its claim language, targeting specific chemical structures and therapeutic methods.
  • A balanced approach in claim drafting allows broad protection while maintaining validity against prior art.
  • The patent landscape involves numerous related patents, necessitating strategic navigation to avoid infringement and secure market position.
  • The patent's strength derives from its novelty and inventive step over existing compounds, formulations, or methods.
  • Continuous monitoring of legal developments and patent expirations is essential for maximizing commercial value and strategic planning.

FAQs

1. What is the main innovation protected by U.S. Patent 9,980,983?
The patent likely protects a novel chemical compound or class, a specific method of treatment, or a formulation linked to a therapeutic application. Its claims specify unique structural features or uses that distinguish it from prior art.

2. How broad are the claims in the '983 patent?
While the exact scope depends on the claim language, patents of this nature typically include broad independent claims covering the chemical class or therapeutic method, supplemented by narrower dependent claims. The breadth aims to prevent easy design-around but must withstand legal scrutiny.

3. How does the patent landscape influence this patent's enforceability?
Existing patents in related chemical or treatment areas can serve as barriers. A dense patent landscape might require careful licensing or patent clearance strategies to avoid infringement and leverage the patent estate effectively.

4. Can competitors develop similar drugs outside the patent's claims?
Yes. They can explore different chemical classes or therapeutic approaches not covered by the patent. Strategic patent hunting and field analysis guide such innovation efforts.

5. What is the strategic importance of this patent for drug commercialization?
It offers a competitive edge by preventing unauthorized use, enabling licensing revenue, and supporting market exclusivity, crucial for recouping R&D investments and launching new therapies.


Sources:
[1] USPTO Patent Database. Patent No. 9,980,983.
[2] Patent claim and legal analysis reports.
[3] Patent landscape studies of related pharmaceutical patents.

More… ↓

⤷  Get Started Free


Drugs Protected by US Patent 9,980,983

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Aclaris ESKATA hydrogen peroxide SOLUTION;TOPICAL 209305-001 Dec 14, 2017 DISCN Yes No ⤷  Get Started Free ⤷  Get Started Free TREATMENT OF SEBORRHEIC KERATOSES THAT ARE RAISED ⤷  Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 9,980,983

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2015249841 ⤷  Get Started Free
Brazil 112016024630 ⤷  Get Started Free
Canada 2946568 ⤷  Get Started Free
China 106659643 ⤷  Get Started Free
Denmark 3134061 ⤷  Get Started Free
European Patent Office 3134061 ⤷  Get Started Free
Spain 2828711 ⤷  Get Started Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.